BIO.B: Bio-Rad Laboratories, Inc. Stock

SIC 3826 – Laboratory Analytical Instruments

Valuation
Market Cap ($M) 0.00
Enterprise Value ($M) 766.10
Book Value ($M) 9,051.13
Book Value / Share 317.31
Price / Book 0.00
NCAV ($M) -497.82
NCAV / Share -17.45
Price / NCAV 0.00

Profitability (mra)
Return on Invested Capital (ROIC) -0.03
Return on Assets (ROA) -0.02
Return on Equity (ROE) -0.03

Liquidity (mrq)
Quick Ratio 4.89
Current Ratio 6.57

Balance Sheet (mrq) ($M)
Current Assets 3,060.94
Assets 12,609.89
Liabilities 3,558.76
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 2,671.26
Operating Income 355.19
Net Income -637.32
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 374.94
Cash from Investing 20.21
Cash from Financing -425.65

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT P
2024-02-16 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2023 OR ☐ TRANSITION REPORT PUR
2023-10-27 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 ☐ TRANSITION REPO
2023-08-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 ☐ TRANSITION REPORT PU

(click for more detail)

Similar Companies
AME – AMETEK, Inc. AVTR – Avantor, Inc.
BIO – Bio-Rad Laboratories, Inc. BMI – Badger Meter, Inc.
COHR – Coherent Corp.


Financial data and stock pages provided by
Fintel.io